Document Preview Unavailable
Efficacy and Safety of Fixed-Dose Esketamine Nasal Spray Combined With a New Oral Antidepressant in Treatment-Resistant Depression: Results of a Randomized, Double-Blind, Active-Controlled Study (TRANSFORM-1)
You might have access to this document
-
Try and log in through your institution to see if they have access to the full text.
Log in through your library